Edgewell Personal Care Co
Edgewell Personal Care Co operates in the Household & Personal Products industry, generating revenue through the sale of personal care goods.
Business. Edgewell Personal Care Co (EPC.O) is a household and personal products company that operates within the Non-Cyclical Consumer Goods & Services sector. The firm generates revenue through the sale of personal and household products. Headquartered in the United States, the company is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic mix are not provided.
Analyst recommendations
7 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsFY 2026 earnings (expected)2026-11-09 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Edgewell Personal Care Co (EPC.O) is a household and personal products company that operates within the Non-Cyclical Consumer Goods & Services sector. The firm generates revenue through the sale of personal and household products. Headquartered in the United States, the company is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic mix are not provided.
Edgewell Personal Care Co maintains a capital structure characterized by significant leverage, with long-term debt of $1.38 billion against total equity of $1.55 billion, resulting in a debt-to-equity ratio of 0.89. The company trades at a price-to-book ratio of 0.76, indicating the market values the firm below its book value. Liquidity is assessed as medium risk, with a key flag noting that net cash is negative after subtracting total debt. Operating cash flow stands at $118.4 million, which covers capital expenditures of $77.0 million, providing positive free cash flow despite the high debt load.
Profitability metrics are currently compressed, with a return on equity of 1.64% and a return on assets of 0.68%. The price-to-earnings ratio is elevated at 46.63, reflecting low net income of $25.4 million relative to the market capitalization of $1.18 billion. Gross profit is $924.9 million on revenue of $2.22 billion, yielding a gross margin of approximately 41.6%, but operating income is only $96.6 million, suggesting high operating expenses or restructuring costs impacting the bottom line.
Segment and geographic data are not provided in the current input, preventing a detailed analysis of revenue concentration or regional exposure. The company's activity is broadly defined as Household & Personal Products within the Consumer Staples sector.
Growth trajectory analysis is limited by the absence of historical period data in the input. The current revenue base is $2.22 billion, but year-over-year trends cannot be established from the available snapshot.
Risk assessment highlights medium liquidity risk and low dilution risk. The primary financial concern is the negative net cash position, which constrains financial flexibility. The debt-to-equity ratio of 0.89 is a notable leverage metric that requires monitoring in the context of interest rate environments.
Recent IR observations indicate a mean analyst price target of $24.50, which is below the current market price of $25.49, suggesting limited upside consensus. The mean recommendation is 2.57, with three buy ratings and four hold ratings, reflecting a neutral-to-positive but cautious sentiment among analysts.
- The company trades at a discount to book value (P/B 0.76) but carries a high P/E (46.63) due to suppressed earnings.
- Leverage is significant with a debt-to-equity ratio of 0.89 and negative net cash, creating medium liquidity risk.
- Operating cash flow of $118.4 million comfortably covers capital expenditures of $77.0 million.
- Analyst sentiment is mixed with a mean recommendation of 2.57 and a price target below the current market price.
- Profitability is weak with ROE of 1.64% and ROA of 0.68%, indicating operational inefficiencies or transition costs.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Restricted Stock Equivalents 2-5-2026 → Common StockAcquired 7 817grant · 2026-02-05
- Director · Restricted Stock Equivalents 2-5-2026 → Common StockAcquired 7 817grant · 2026-02-05
- Director · Restricted Stock Equivalents 2-5-2026 → Common StockAcquired 7 817grant · 2026-02-05
- Director · Restricted Stock Equivalents 2-5-2026 → Common StockAcquired 7 817grant · 2026-02-05
- Director · Restricted Stock Equivalents 2-5-2026 → Common StockAcquired 7 817grant · 2026-02-05
- Director · Restricted Stock Equivalents 2-5-2026 → Common StockAcquired 7 817grant · 2026-02-05
- Director · Restricted Stock Equivalents 2-5-2026 → Common StockAcquired 7 817grant · 2026-02-05
- Director · Restricted Stock Equivalents 2-5-2026 → Common StockAcquired 7 817grant · 2026-02-05
- CFO · Restricted Stock Equivalents 12-2-2024 → Common StockDisposed 2 296exercise · 2025-12-02
- CFO · Restricted Stock Equivalents 11-14-2025 → Common StockAcquired 26 476grant · 2025-11-14
- President, North America · Common Stock → Common StockAcquired 26 476grant · 2025-11-14
- Chief Accounting Officer · Restricted Stock Equivalents 11/14/2025 → Common StockAcquired 3 586grant · 2025-11-14
- Director, Chief Executive Officer · Restricted Stock Equivalents 11/14/2025 → Common StockAcquired 103 420grant · 2025-11-14
- Chief Supply Chain Officer · Restricted Stock Equivalents 11-14-2025 → Common StockAcquired 15 445grant · 2025-11-14
- Chief People & Legal Officer · Restricted Stock Equivalents 11-14-2025 → Common StockAcquired 24 270grant · 2025-11-14
- Chief Supply Chain Officer · Performance Stock Equialents 11-8-2024 → Common StockDisposed 4 149exercise · 2025-11-13
- Director, Chief Executive Officer · Performance Stock Equivalents 11-11-2022 → Common StockDisposed 58 612exercise · 2025-11-13
- Chief People & Legal Officer · Performance Stock Award 11-11-2022 → Common StockDisposed 5 773exercise · 2025-11-13
- CFO · Performance Stock Equivalents 11-11-2022 → Common StockDisposed 2 754exercise · 2025-11-13
- Chief Supply Chain Officer · Performance Stock Equivalents 11-11-2022 → Common StockDisposed 5 773exercise · 2025-11-13
- Chief Supply Chain Officer · Restricted Stock Equivalents 11-11-2022 → Common StockDisposed 1 635exercise · 2025-11-11
- CFO · Restricted Stock Equivalents 11/11/2022 → Common StockDisposed 780exercise · 2025-11-11
- Chief People & Legal Officer · Restricted Stock Equivalents 11-11-2022 → Common StockDisposed 1 635exercise · 2025-11-11
- Director, Chief Executive Officer · Restricted Stock Equivalents 11-11-2022 → Common StockDisposed 5 830exercise · 2025-11-11
- Chief People & Legal Officer · Restricted Stock Equivalents 11-10-2023 → Common StockDisposed 2 338exercise · 2025-11-10
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Capex To Revenuecapital_expenditure / revenue
- Ev To Revenueenterprise_value / revenue
- Market Capmarket_price * shares_outstanding_diluted
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Return On Equitynet_income / total_equity
- Return On Assetsnet_income / total_assets
- EDGEWELL PERSONAL CARE COMPANY Market data — financials · 2026-06-25
- Edgewell Personal Care Co Market data — analyst estimates · 2026-06-25
- Edgewell Personal Care Co Market data — ESG · 2026-06-25
- Edgewell Personal Care Co HA canonical relationships · 2026-06-25
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,05 %$91M
- Investment Managers · as of 2026-03-310,01 %$52M
- Investment Managers · as of 2024-06-300,01 %$308M
- Investment Managers · as of 2026-03-310,00 %$23M
- Institutional Investor · as of 2026-03-310,00 %$15M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$17M
- Investment Managers · as of 2026-03-310,00 %$13M
- Funds · as of 2026-03-310,00 %$12M
- Investment Managers · as of 2026-03-310,00 %$24M
- Investment Managers · as of 2026-03-310,00 %$11M
- Investment Managers · as of 2025-12-310,00 %$94M
- Investment Managers · as of 2026-03-310,00 %$38M
- Investment Managers · as of 2024-12-310,00 %$4M
- Institutional Investor · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$11M
- Institutional Investor · as of 2022-09-300,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$5M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
- CFO · Common StockOther 798 @ $17,00$14K · 2025-12-02
- CFO · Common StaockOther 2 296 · 2025-12-02
- Chief Accounting Officer · Common StockSold 333 @ $17,21$6K · 2025-11-20
- CFO · Common StockOther 958 @ $18,39$18K · 2025-11-13
- Chief Supply Chain Officer · Common StockOther 5 773 · 2025-11-13
- Chief Supply Chain Officer · Common StockOther 2 676 @ $18,39$49K · 2025-11-13
- Chief Supply Chain Officer · Common StockOther 4 149 · 2025-11-13
- Chief Supply Chain Officer · Common StockOther 1 924 @ $18,39$35K · 2025-11-13
- Director, Chief Executive Officer · Common StockOther 58 612 · 2025-11-13
- Chief People & Legal Officer · Common StockOther 5 773 · 2025-11-13
- Director, Chief Executive Officer · Common StockOther 27 167 @ $18,39$500K · 2025-11-13
- Chief People & Legal Officer · Common StockOther 2 873 @ $18,39$53K · 2025-11-13
- CFO · Common StockOther 2 754 · 2025-11-13
- Director, Chief Executive Officer · Common StockOther 5 830 @ $18,57$108K · 2025-11-11
- Chief Supply Chain Officer · Common StockOther 758 @ $18,57$14K · 2025-11-11
- Chief People & Legal Officer · Common StockOther 1 635 · 2025-11-11
- CFO · Common StockOther 272 @ $18,57$5K · 2025-11-11
- Director, Chief Executive Officer · Common StockOther 12 578 · 2025-11-11
- Chief People & Legal Officer · Common StockOther 814 @ $18,57$15K · 2025-11-11
- CFO · Common StockOther 780 · 2025-11-11
- Chief Supply Chain Officer · Common StockOther 1 635 · 2025-11-11
- CFO · Common StockOther 356 @ $18,83$7K · 2025-11-10
- Chief Supply Chain Officer · Common StockOther 2 046 · 2025-11-10
- Chief Supply Chain Officer · Common StockOther 949 @ $18,83$18K · 2025-11-10
- Chief People & Legal Officer · Common StockOther 2 338 · 2025-11-10
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Shares outstanding (annual): 46.72MUnknown
- Current assets (annual): USD 1.06BUnknown
- Shareholders' equity (annual): USD 1.49BUnknown
- Total assets (annual): USD 3.77BUnknown
- Current liabilities (annual): USD 497.5MUnknown
- Total liabilities (annual): USD 2.28BUnknown
- Long-term debt (annual): USD 1.53BUnknown
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -1.0%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 1.8%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 1.54xDerived (calculated)
- Current ratio (FY 2025-12-31): 2.12xDerived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 5.4%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 3.6%Derived (calculated)
- Revenue (annual): USD 2.22BUnknown
- EPS (basic) (annual): USD-PER-SHARES 1Unknown
- Pre-tax income (annual): USD 23.6MUnknown
- Interest expense (annual): USD 73.2MUnknown
- Gross profit (annual): USD 924.9MUnknown
- EPS (diluted) (annual): USD-PER-SHARES 1Unknown
- Cost of revenue (annual): USD 1.3BUnknown
- Net income (annual): USD 25.4MUnknown
- Operating cash flow (annual): USD 118.4MUnknown
- R&D expense (annual): USD 57.6MUnknown
- Operating income (annual): USD 96.6MUnknown